As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

Dominique Johnson, who had worked for the Internal Revenue Service for 15 years, died on Jan. 30 at the age of 40 after an ...

Cervical cancer is the fourth most common cancer among women worldwide. In India, where it is the second most common, it ...

Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

Cervical cancer is a major health issue for Indian women, primarily caused by HPV. Key symptoms include abnormal bleeding and ...

A cervical cancer drug may elevate the risk of developing ocular surface disease, such as conjunctival scarring and infectious keratitis.

Cervical cancer is caused by human papillomavirus HPV and has become a major health concern Read this article to know ...

Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating advanced cervical cancer by ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...